Madrigal Pharmaceuticals
MDGL
MDGL
208 hedge funds and large institutions have $3.43B invested in Madrigal Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
-14
Holders Change %
-6.31%
% of All Funds
3.28%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.14%
New
34
Increased
88
Reduced
58
Closed
46
Calls
$440M
Puts
$260M
Net Calls
+$180M
Net Calls Change
-$55.5M
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$343M |
| 2 |
PC
2
Paulson & Co
New York
|
$80.9M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$85.7M |
| 4 |
O
4
OrbiMed
New York
|
$74.3M |
| 5 |
RI
5
RTW Investments
New York
|
$51.2M |